Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Ethosomes are a promising way to deliver drugs through the skin.

Vitamin D is crucial for skin health and managing skin diseases.

Moxibustion may help improve ovarian function by changing androgen levels.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

SHBG may be a useful early indicator and treatment target for PCOS.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.